nodes	percent_of_prediction	percent_of_DWPC	metapath
Clonidine—ABCB1—esophageal cancer	0.493	1	CbGaD
Clonidine—SLC22A4—larynx—esophageal cancer	0.014	0.165	CbGeAlD
Clonidine—Paresthesia of limbs—Methotrexate—esophageal cancer	0.00503	0.0325	CcSEcCtD
Clonidine—Lower respiratory tract infection—Capecitabine—esophageal cancer	0.00379	0.0245	CcSEcCtD
Clonidine—NISCH—bronchus—esophageal cancer	0.00376	0.0443	CbGeAlD
Clonidine—SLC22A4—neck—esophageal cancer	0.00371	0.0437	CbGeAlD
Clonidine—NISCH—smooth muscle tissue—esophageal cancer	0.00368	0.0434	CbGeAlD
Clonidine—NISCH—trachea—esophageal cancer	0.00337	0.0398	CbGeAlD
Clonidine—ADRA1D—epithelium—esophageal cancer	0.00319	0.0376	CbGeAlD
Clonidine—Rash macular—Capecitabine—esophageal cancer	0.00316	0.0204	CcSEcCtD
Clonidine—SLC22A4—bronchus—esophageal cancer	0.00249	0.0293	CbGeAlD
Clonidine—NISCH—lung—esophageal cancer	0.00242	0.0286	CbGeAlD
Clonidine—Sneezing—Capecitabine—esophageal cancer	0.00234	0.0151	CcSEcCtD
Clonidine—SLC22A4—trachea—esophageal cancer	0.00223	0.0263	CbGeAlD
Clonidine—SLC22A3—smooth muscle tissue—esophageal cancer	0.00221	0.0261	CbGeAlD
Clonidine—Skin hyperpigmentation—Capecitabine—esophageal cancer	0.00218	0.0141	CcSEcCtD
Clonidine—Rhinorrhoea—Cisplatin—esophageal cancer	0.00217	0.014	CcSEcCtD
Clonidine—Infection—Carboplatin—esophageal cancer	0.00212	0.0137	CcSEcCtD
Clonidine—Loss of libido—Methotrexate—esophageal cancer	0.00209	0.0135	CcSEcCtD
Clonidine—SLC22A4—digestive system—esophageal cancer	0.00192	0.0226	CbGeAlD
Clonidine—Ileus—Capecitabine—esophageal cancer	0.00183	0.0118	CcSEcCtD
Clonidine—ADRA1A—epithelium—esophageal cancer	0.00183	0.0216	CbGeAlD
Clonidine—Pain—Carboplatin—esophageal cancer	0.00183	0.0118	CcSEcCtD
Clonidine—Throat sore—Capecitabine—esophageal cancer	0.0018	0.0116	CcSEcCtD
Clonidine—Oropharyngeal discomfort—Capecitabine—esophageal cancer	0.00178	0.0115	CcSEcCtD
Clonidine—ADRA2C—bronchus—esophageal cancer	0.00172	0.0202	CbGeAlD
Clonidine—Body temperature increased—Carboplatin—esophageal cancer	0.00169	0.0109	CcSEcCtD
Clonidine—Skin ulcer—Capecitabine—esophageal cancer	0.00167	0.0107	CcSEcCtD
Clonidine—NISCH—lymph node—esophageal cancer	0.00166	0.0196	CbGeAlD
Clonidine—Hyperaesthesia—Capecitabine—esophageal cancer	0.00165	0.0107	CcSEcCtD
Clonidine—SLC22A5—bronchus—esophageal cancer	0.00164	0.0194	CbGeAlD
Clonidine—Skin hyperpigmentation—Methotrexate—esophageal cancer	0.00162	0.0105	CcSEcCtD
Clonidine—SLC22A4—lung—esophageal cancer	0.0016	0.0189	CbGeAlD
Clonidine—Rhinorrhoea—Capecitabine—esophageal cancer	0.0016	0.0103	CcSEcCtD
Clonidine—ADRA2C—trachea—esophageal cancer	0.00154	0.0182	CbGeAlD
Clonidine—Hypoxia—Methotrexate—esophageal cancer	0.00152	0.0098	CcSEcCtD
Clonidine—CYP1A1—epithelium—esophageal cancer	0.00149	0.0176	CbGeAlD
Clonidine—SLC22A5—trachea—esophageal cancer	0.00148	0.0174	CbGeAlD
Clonidine—CYP1A1—bronchus—esophageal cancer	0.00147	0.0173	CbGeAlD
Clonidine—SLC22A3—lung—esophageal cancer	0.00146	0.0172	CbGeAlD
Clonidine—Oropharyngeal pain—Capecitabine—esophageal cancer	0.00143	0.0092	CcSEcCtD
Clonidine—Cardiac failure congestive—Cisplatin—esophageal cancer	0.00141	0.00908	CcSEcCtD
Clonidine—Nasal congestion—Cisplatin—esophageal cancer	0.0014	0.00904	CcSEcCtD
Clonidine—Nocturia—Capecitabine—esophageal cancer	0.0014	0.00902	CcSEcCtD
Clonidine—ADRA2A—bronchus—esophageal cancer	0.00137	0.0162	CbGeAlD
Clonidine—CYP1A1—trachea—esophageal cancer	0.00132	0.0156	CbGeAlD
Clonidine—Cerebrovascular accident—Cisplatin—esophageal cancer	0.0013	0.0084	CcSEcCtD
Clonidine—SLC22A5—digestive system—esophageal cancer	0.00127	0.015	CbGeAlD
Clonidine—Influenza like illness—Capecitabine—esophageal cancer	0.00126	0.00812	CcSEcCtD
Clonidine—SLC6A2—lung—esophageal cancer	0.00125	0.0147	CbGeAlD
Clonidine—Skin ulcer—Methotrexate—esophageal cancer	0.00124	0.008	CcSEcCtD
Clonidine—ADRA2A—trachea—esophageal cancer	0.00123	0.0145	CbGeAlD
Clonidine—Irritability—Cisplatin—esophageal cancer	0.00122	0.00786	CcSEcCtD
Clonidine—Dry eye—Capecitabine—esophageal cancer	0.0012	0.00773	CcSEcCtD
Clonidine—Orthostatic hypotension—Cisplatin—esophageal cancer	0.00117	0.00752	CcSEcCtD
Clonidine—Breast disorder—Cisplatin—esophageal cancer	0.00115	0.00744	CcSEcCtD
Clonidine—CYP1A2—digestive system—esophageal cancer	0.00115	0.0136	CbGeAlD
Clonidine—Cramp muscle—Cisplatin—esophageal cancer	0.00115	0.00742	CcSEcCtD
Clonidine—Nasopharyngitis—Cisplatin—esophageal cancer	0.00114	0.00737	CcSEcCtD
Clonidine—CYP1A1—digestive system—esophageal cancer	0.00114	0.0134	CbGeAlD
Clonidine—CYP3A5—digestive system—esophageal cancer	0.00111	0.0131	CbGeAlD
Clonidine—ADRA2C—lung—esophageal cancer	0.00111	0.0131	CbGeAlD
Clonidine—Ear pain—Capecitabine—esophageal cancer	0.0011	0.00712	CcSEcCtD
Clonidine—SLC22A4—lymph node—esophageal cancer	0.0011	0.0129	CbGeAlD
Clonidine—Sleep disorder—Capecitabine—esophageal cancer	0.00109	0.00701	CcSEcCtD
Clonidine—SLC22A5—lung—esophageal cancer	0.00106	0.0125	CbGeAlD
Clonidine—Libido decreased—Capecitabine—esophageal cancer	0.00101	0.00655	CcSEcCtD
Clonidine—SLC22A3—lymph node—esophageal cancer	0.000998	0.0118	CbGeAlD
Clonidine—Thirst—Capecitabine—esophageal cancer	0.000989	0.00638	CcSEcCtD
Clonidine—Respiratory failure—Methotrexate—esophageal cancer	0.000983	0.00634	CcSEcCtD
Clonidine—CYP1A2—lung—esophageal cancer	0.000961	0.0113	CbGeAlD
Clonidine—Cerebrovascular accident—Capecitabine—esophageal cancer	0.00096	0.0062	CcSEcCtD
Clonidine—Lethargy—Capecitabine—esophageal cancer	0.00096	0.0062	CcSEcCtD
Clonidine—CYP1A1—lung—esophageal cancer	0.000948	0.0112	CbGeAlD
Clonidine—Pain in extremity—Capecitabine—esophageal cancer	0.000941	0.00607	CcSEcCtD
Clonidine—Disturbance in sexual arousal—Capecitabine—esophageal cancer	0.000934	0.00602	CcSEcCtD
Clonidine—CYP3A5—lung—esophageal cancer	0.000927	0.0109	CbGeAlD
Clonidine—Bradycardia—Cisplatin—esophageal cancer	0.000899	0.0058	CcSEcCtD
Clonidine—Irritability—Capecitabine—esophageal cancer	0.000898	0.00579	CcSEcCtD
Clonidine—Urinary retention—Capecitabine—esophageal cancer	0.000895	0.00577	CcSEcCtD
Clonidine—ADRA2A—lung—esophageal cancer	0.000884	0.0104	CbGeAlD
Clonidine—Liver function test abnormal—Capecitabine—esophageal cancer	0.000869	0.00561	CcSEcCtD
Clonidine—Gynaecomastia—Methotrexate—esophageal cancer	0.000863	0.00557	CcSEcCtD
Clonidine—Orthostatic hypotension—Capecitabine—esophageal cancer	0.000859	0.00555	CcSEcCtD
Clonidine—Abdominal pain upper—Capecitabine—esophageal cancer	0.000859	0.00555	CcSEcCtD
Clonidine—SLC6A2—lymph node—esophageal cancer	0.000855	0.0101	CbGeAlD
Clonidine—Breast disorder—Capecitabine—esophageal cancer	0.00085	0.00549	CcSEcCtD
Clonidine—Nasopharyngitis—Capecitabine—esophageal cancer	0.000841	0.00543	CcSEcCtD
Clonidine—CYP3A4—digestive system—esophageal cancer	0.000833	0.00982	CbGeAlD
Clonidine—Eye disorder—Cisplatin—esophageal cancer	0.000825	0.00532	CcSEcCtD
Clonidine—Tinnitus—Cisplatin—esophageal cancer	0.000823	0.00531	CcSEcCtD
Clonidine—CYP2D6—digestive system—esophageal cancer	0.00082	0.00967	CbGeAlD
Clonidine—Cardiac disorder—Cisplatin—esophageal cancer	0.00082	0.00529	CcSEcCtD
Clonidine—Asthma—Capecitabine—esophageal cancer	0.000813	0.00525	CcSEcCtD
Clonidine—Diclofenac—PTGS1—esophageal cancer	0.000798	0.486	CrCbGaD
Clonidine—Mediastinal disorder—Cisplatin—esophageal cancer	0.000796	0.00514	CcSEcCtD
Clonidine—Arrhythmia—Cisplatin—esophageal cancer	0.000789	0.00509	CcSEcCtD
Clonidine—Alopecia—Cisplatin—esophageal cancer	0.00078	0.00503	CcSEcCtD
Clonidine—ABCB1—epithelium—esophageal cancer	0.000775	0.00914	CbGeAlD
Clonidine—Erythema—Cisplatin—esophageal cancer	0.000769	0.00496	CcSEcCtD
Clonidine—Dysuria—Capecitabine—esophageal cancer	0.000761	0.00491	CcSEcCtD
Clonidine—ADRA2C—lymph node—esophageal cancer	0.000758	0.00893	CbGeAlD
Clonidine—Upper respiratory tract infection—Capecitabine—esophageal cancer	0.000756	0.00488	CcSEcCtD
Clonidine—Weight increased—Capecitabine—esophageal cancer	0.00074	0.00478	CcSEcCtD
Clonidine—Muscle spasms—Cisplatin—esophageal cancer	0.000739	0.00477	CcSEcCtD
Clonidine—SLC22A5—lymph node—esophageal cancer	0.000726	0.00856	CbGeAlD
Clonidine—Vision blurred—Cisplatin—esophageal cancer	0.000725	0.00467	CcSEcCtD
Clonidine—Depression—Capecitabine—esophageal cancer	0.000723	0.00467	CcSEcCtD
Clonidine—Tremor—Cisplatin—esophageal cancer	0.00072	0.00465	CcSEcCtD
Clonidine—Cerebrovascular accident—Methotrexate—esophageal cancer	0.000715	0.00461	CcSEcCtD
Clonidine—Lethargy—Methotrexate—esophageal cancer	0.000715	0.00461	CcSEcCtD
Clonidine—Ill-defined disorder—Cisplatin—esophageal cancer	0.000713	0.0046	CcSEcCtD
Clonidine—Urinary tract infection—Capecitabine—esophageal cancer	0.000705	0.00455	CcSEcCtD
Clonidine—Malaise—Cisplatin—esophageal cancer	0.000693	0.00447	CcSEcCtD
Clonidine—ABCB1—trachea—esophageal cancer	0.000685	0.00808	CbGeAlD
Clonidine—Epistaxis—Capecitabine—esophageal cancer	0.000684	0.00441	CcSEcCtD
Clonidine—Irritability—Methotrexate—esophageal cancer	0.000669	0.00431	CcSEcCtD
Clonidine—Bradycardia—Capecitabine—esophageal cancer	0.000663	0.00428	CcSEcCtD
Clonidine—Rhinitis—Capecitabine—esophageal cancer	0.000653	0.00421	CcSEcCtD
Clonidine—Anxiety—Cisplatin—esophageal cancer	0.000652	0.00421	CcSEcCtD
Clonidine—Hepatitis—Capecitabine—esophageal cancer	0.000651	0.0042	CcSEcCtD
Clonidine—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—esophageal cancer	0.00065	0.00419	CcSEcCtD
Clonidine—CYP1A1—lymph node—esophageal cancer	0.000648	0.00765	CbGeAlD
Clonidine—Hypoaesthesia—Capecitabine—esophageal cancer	0.000648	0.00418	CcSEcCtD
Clonidine—Liver function test abnormal—Methotrexate—esophageal cancer	0.000647	0.00417	CcSEcCtD
Clonidine—Discomfort—Cisplatin—esophageal cancer	0.000647	0.00417	CcSEcCtD
Clonidine—Breast disorder—Methotrexate—esophageal cancer	0.000633	0.00408	CcSEcCtD
Clonidine—Oedema—Cisplatin—esophageal cancer	0.000627	0.00405	CcSEcCtD
Clonidine—Infection—Cisplatin—esophageal cancer	0.000623	0.00402	CcSEcCtD
Clonidine—Nervous system disorder—Cisplatin—esophageal cancer	0.000615	0.00397	CcSEcCtD
Clonidine—Thrombocytopenia—Cisplatin—esophageal cancer	0.000614	0.00396	CcSEcCtD
Clonidine—Tachycardia—Cisplatin—esophageal cancer	0.000612	0.00395	CcSEcCtD
Clonidine—Skin disorder—Cisplatin—esophageal cancer	0.000609	0.00393	CcSEcCtD
Clonidine—Eye disorder—Capecitabine—esophageal cancer	0.000608	0.00393	CcSEcCtD
Clonidine—Tinnitus—Capecitabine—esophageal cancer	0.000607	0.00392	CcSEcCtD
Clonidine—Hyperhidrosis—Cisplatin—esophageal cancer	0.000607	0.00391	CcSEcCtD
Clonidine—Asthma—Methotrexate—esophageal cancer	0.000605	0.00391	CcSEcCtD
Clonidine—ADRA2A—lymph node—esophageal cancer	0.000604	0.00713	CbGeAlD
Clonidine—Cardiac disorder—Capecitabine—esophageal cancer	0.000604	0.0039	CcSEcCtD
Clonidine—Anorexia—Cisplatin—esophageal cancer	0.000598	0.00386	CcSEcCtD
Clonidine—Angiopathy—Capecitabine—esophageal cancer	0.000591	0.00381	CcSEcCtD
Clonidine—ABCB1—digestive system—esophageal cancer	0.00059	0.00695	CbGeAlD
Clonidine—Mediastinal disorder—Capecitabine—esophageal cancer	0.000587	0.00379	CcSEcCtD
Clonidine—Hypotension—Cisplatin—esophageal cancer	0.000586	0.00378	CcSEcCtD
Clonidine—Arrhythmia—Capecitabine—esophageal cancer	0.000582	0.00375	CcSEcCtD
Clonidine—Alopecia—Capecitabine—esophageal cancer	0.000575	0.00371	CcSEcCtD
Clonidine—Musculoskeletal discomfort—Cisplatin—esophageal cancer	0.000572	0.00369	CcSEcCtD
Clonidine—Mental disorder—Capecitabine—esophageal cancer	0.00057	0.00368	CcSEcCtD
Clonidine—Erythema—Capecitabine—esophageal cancer	0.000567	0.00366	CcSEcCtD
Clonidine—Dysuria—Methotrexate—esophageal cancer	0.000566	0.00365	CcSEcCtD
Clonidine—Paraesthesia—Cisplatin—esophageal cancer	0.000563	0.00363	CcSEcCtD
Clonidine—Upper respiratory tract infection—Methotrexate—esophageal cancer	0.000563	0.00363	CcSEcCtD
Clonidine—Dyspnoea—Cisplatin—esophageal cancer	0.000559	0.00361	CcSEcCtD
Clonidine—Erectile dysfunction—Methotrexate—esophageal cancer	0.000558	0.0036	CcSEcCtD
Clonidine—Decreased appetite—Cisplatin—esophageal cancer	0.000545	0.00352	CcSEcCtD
Clonidine—Muscle spasms—Capecitabine—esophageal cancer	0.000545	0.00352	CcSEcCtD
Clonidine—Gastrointestinal disorder—Cisplatin—esophageal cancer	0.000542	0.00349	CcSEcCtD
Clonidine—Drowsiness—Methotrexate—esophageal cancer	0.00054	0.00348	CcSEcCtD
Clonidine—Depression—Methotrexate—esophageal cancer	0.000538	0.00347	CcSEcCtD
Clonidine—Pain—Cisplatin—esophageal cancer	0.000537	0.00346	CcSEcCtD
Clonidine—Vision blurred—Capecitabine—esophageal cancer	0.000534	0.00345	CcSEcCtD
Clonidine—Tremor—Capecitabine—esophageal cancer	0.000531	0.00343	CcSEcCtD
Clonidine—Ill-defined disorder—Capecitabine—esophageal cancer	0.000526	0.00339	CcSEcCtD
Clonidine—Sweating—Methotrexate—esophageal cancer	0.000518	0.00334	CcSEcCtD
Clonidine—Feeling abnormal—Cisplatin—esophageal cancer	0.000517	0.00334	CcSEcCtD
Clonidine—Malaise—Capecitabine—esophageal cancer	0.000511	0.0033	CcSEcCtD
Clonidine—Epistaxis—Methotrexate—esophageal cancer	0.000509	0.00329	CcSEcCtD
Clonidine—Syncope—Capecitabine—esophageal cancer	0.000508	0.00328	CcSEcCtD
Clonidine—Palpitations—Capecitabine—esophageal cancer	0.000501	0.00323	CcSEcCtD
Clonidine—Loss of consciousness—Capecitabine—esophageal cancer	0.000498	0.00321	CcSEcCtD
Clonidine—Body temperature increased—Cisplatin—esophageal cancer	0.000496	0.0032	CcSEcCtD
Clonidine—Cough—Capecitabine—esophageal cancer	0.000494	0.00319	CcSEcCtD
Clonidine—ABCB1—lung—esophageal cancer	0.000492	0.00581	CbGeAlD
Clonidine—Hepatitis—Methotrexate—esophageal cancer	0.000485	0.00313	CcSEcCtD
Clonidine—Chest pain—Capecitabine—esophageal cancer	0.000482	0.00311	CcSEcCtD
Clonidine—Arthralgia—Capecitabine—esophageal cancer	0.000482	0.00311	CcSEcCtD
Clonidine—Anxiety—Capecitabine—esophageal cancer	0.000481	0.0031	CcSEcCtD
Clonidine—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—esophageal cancer	0.000479	0.00309	CcSEcCtD
Clonidine—Discomfort—Capecitabine—esophageal cancer	0.000477	0.00308	CcSEcCtD
Clonidine—Dry mouth—Capecitabine—esophageal cancer	0.000472	0.00304	CcSEcCtD
Clonidine—Confusional state—Capecitabine—esophageal cancer	0.000466	0.00301	CcSEcCtD
Clonidine—Oedema—Capecitabine—esophageal cancer	0.000462	0.00298	CcSEcCtD
Clonidine—Hypersensitivity—Cisplatin—esophageal cancer	0.000462	0.00298	CcSEcCtD
Clonidine—Infection—Capecitabine—esophageal cancer	0.000459	0.00296	CcSEcCtD
Clonidine—Diclofenac—PTGS2—esophageal cancer	0.000456	0.278	CrCbGaD
Clonidine—Shock—Capecitabine—esophageal cancer	0.000455	0.00294	CcSEcCtD
Clonidine—Nervous system disorder—Capecitabine—esophageal cancer	0.000454	0.00293	CcSEcCtD
Clonidine—Eye disorder—Methotrexate—esophageal cancer	0.000453	0.00292	CcSEcCtD
Clonidine—Thrombocytopenia—Capecitabine—esophageal cancer	0.000453	0.00292	CcSEcCtD
Clonidine—Tinnitus—Methotrexate—esophageal cancer	0.000452	0.00292	CcSEcCtD
Clonidine—Tachycardia—Capecitabine—esophageal cancer	0.000451	0.00291	CcSEcCtD
Clonidine—Asthenia—Cisplatin—esophageal cancer	0.00045	0.0029	CcSEcCtD
Clonidine—Cardiac disorder—Methotrexate—esophageal cancer	0.00045	0.0029	CcSEcCtD
Clonidine—Skin disorder—Capecitabine—esophageal cancer	0.000449	0.0029	CcSEcCtD
Clonidine—Hyperhidrosis—Capecitabine—esophageal cancer	0.000447	0.00288	CcSEcCtD
Clonidine—Anorexia—Capecitabine—esophageal cancer	0.000441	0.00284	CcSEcCtD
Clonidine—Angiopathy—Methotrexate—esophageal cancer	0.00044	0.00284	CcSEcCtD
Clonidine—Mediastinal disorder—Methotrexate—esophageal cancer	0.000437	0.00282	CcSEcCtD
Clonidine—Hypotension—Capecitabine—esophageal cancer	0.000432	0.00279	CcSEcCtD
Clonidine—Diarrhoea—Cisplatin—esophageal cancer	0.000429	0.00277	CcSEcCtD
Clonidine—Alopecia—Methotrexate—esophageal cancer	0.000428	0.00276	CcSEcCtD
Clonidine—Mental disorder—Methotrexate—esophageal cancer	0.000425	0.00274	CcSEcCtD
Clonidine—Erythema—Methotrexate—esophageal cancer	0.000422	0.00272	CcSEcCtD
Clonidine—Musculoskeletal discomfort—Capecitabine—esophageal cancer	0.000421	0.00272	CcSEcCtD
Clonidine—Insomnia—Capecitabine—esophageal cancer	0.000418	0.0027	CcSEcCtD
Clonidine—Paraesthesia—Capecitabine—esophageal cancer	0.000415	0.00268	CcSEcCtD
Clonidine—Dyspnoea—Capecitabine—esophageal cancer	0.000412	0.00266	CcSEcCtD
Clonidine—Decreased appetite—Capecitabine—esophageal cancer	0.000402	0.00259	CcSEcCtD
Clonidine—Gastrointestinal disorder—Capecitabine—esophageal cancer	0.000399	0.00258	CcSEcCtD
Clonidine—Vomiting—Cisplatin—esophageal cancer	0.000399	0.00257	CcSEcCtD
Clonidine—Fatigue—Capecitabine—esophageal cancer	0.000399	0.00257	CcSEcCtD
Clonidine—Vision blurred—Methotrexate—esophageal cancer	0.000398	0.00257	CcSEcCtD
Clonidine—Rash—Cisplatin—esophageal cancer	0.000396	0.00255	CcSEcCtD
Clonidine—Pain—Capecitabine—esophageal cancer	0.000395	0.00255	CcSEcCtD
Clonidine—Constipation—Capecitabine—esophageal cancer	0.000395	0.00255	CcSEcCtD
Clonidine—Dermatitis—Cisplatin—esophageal cancer	0.000395	0.00255	CcSEcCtD
Clonidine—Ill-defined disorder—Methotrexate—esophageal cancer	0.000391	0.00253	CcSEcCtD
Clonidine—Diclofenac—ABCB1—esophageal cancer	0.000388	0.236	CrCbGaD
Clonidine—Feeling abnormal—Capecitabine—esophageal cancer	0.000381	0.00246	CcSEcCtD
Clonidine—Malaise—Methotrexate—esophageal cancer	0.00038	0.00245	CcSEcCtD
Clonidine—Gastrointestinal pain—Capecitabine—esophageal cancer	0.000378	0.00244	CcSEcCtD
Clonidine—Nausea—Cisplatin—esophageal cancer	0.000373	0.0024	CcSEcCtD
Clonidine—Cough—Methotrexate—esophageal cancer	0.000368	0.00238	CcSEcCtD
Clonidine—Urticaria—Capecitabine—esophageal cancer	0.000367	0.00237	CcSEcCtD
Clonidine—Abdominal pain—Capecitabine—esophageal cancer	0.000366	0.00236	CcSEcCtD
Clonidine—Body temperature increased—Capecitabine—esophageal cancer	0.000366	0.00236	CcSEcCtD
Clonidine—Arthralgia—Methotrexate—esophageal cancer	0.000359	0.00232	CcSEcCtD
Clonidine—Chest pain—Methotrexate—esophageal cancer	0.000359	0.00232	CcSEcCtD
Clonidine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—esophageal cancer	0.000357	0.0023	CcSEcCtD
Clonidine—Discomfort—Methotrexate—esophageal cancer	0.000355	0.00229	CcSEcCtD
Clonidine—Confusional state—Methotrexate—esophageal cancer	0.000347	0.00224	CcSEcCtD
Clonidine—Infection—Methotrexate—esophageal cancer	0.000342	0.00221	CcSEcCtD
Clonidine—Hypersensitivity—Capecitabine—esophageal cancer	0.000341	0.0022	CcSEcCtD
Clonidine—Nervous system disorder—Methotrexate—esophageal cancer	0.000338	0.00218	CcSEcCtD
Clonidine—Thrombocytopenia—Methotrexate—esophageal cancer	0.000337	0.00217	CcSEcCtD
Clonidine—ABCB1—lymph node—esophageal cancer	0.000337	0.00397	CbGeAlD
Clonidine—Skin disorder—Methotrexate—esophageal cancer	0.000334	0.00216	CcSEcCtD
Clonidine—Hyperhidrosis—Methotrexate—esophageal cancer	0.000333	0.00215	CcSEcCtD
Clonidine—Asthenia—Capecitabine—esophageal cancer	0.000332	0.00214	CcSEcCtD
Clonidine—Anorexia—Methotrexate—esophageal cancer	0.000328	0.00212	CcSEcCtD
Clonidine—Pruritus—Capecitabine—esophageal cancer	0.000327	0.00211	CcSEcCtD
Clonidine—Hypotension—Methotrexate—esophageal cancer	0.000322	0.00208	CcSEcCtD
Clonidine—Diarrhoea—Capecitabine—esophageal cancer	0.000316	0.00204	CcSEcCtD
Clonidine—Musculoskeletal discomfort—Methotrexate—esophageal cancer	0.000314	0.00202	CcSEcCtD
Clonidine—Insomnia—Methotrexate—esophageal cancer	0.000311	0.00201	CcSEcCtD
Clonidine—Paraesthesia—Methotrexate—esophageal cancer	0.000309	0.00199	CcSEcCtD
Clonidine—Dyspnoea—Methotrexate—esophageal cancer	0.000307	0.00198	CcSEcCtD
Clonidine—Somnolence—Methotrexate—esophageal cancer	0.000306	0.00197	CcSEcCtD
Clonidine—Dizziness—Capecitabine—esophageal cancer	0.000306	0.00197	CcSEcCtD
Clonidine—Decreased appetite—Methotrexate—esophageal cancer	0.000299	0.00193	CcSEcCtD
Clonidine—Gastrointestinal disorder—Methotrexate—esophageal cancer	0.000297	0.00192	CcSEcCtD
Clonidine—Fatigue—Methotrexate—esophageal cancer	0.000297	0.00192	CcSEcCtD
Clonidine—Pain—Methotrexate—esophageal cancer	0.000294	0.0019	CcSEcCtD
Clonidine—Vomiting—Capecitabine—esophageal cancer	0.000294	0.0019	CcSEcCtD
Clonidine—Rash—Capecitabine—esophageal cancer	0.000292	0.00188	CcSEcCtD
Clonidine—Dermatitis—Capecitabine—esophageal cancer	0.000291	0.00188	CcSEcCtD
Clonidine—Headache—Capecitabine—esophageal cancer	0.00029	0.00187	CcSEcCtD
Clonidine—Feeling abnormal—Methotrexate—esophageal cancer	0.000284	0.00183	CcSEcCtD
Clonidine—Gastrointestinal pain—Methotrexate—esophageal cancer	0.000282	0.00182	CcSEcCtD
Clonidine—Nausea—Capecitabine—esophageal cancer	0.000275	0.00177	CcSEcCtD
Clonidine—Urticaria—Methotrexate—esophageal cancer	0.000274	0.00176	CcSEcCtD
Clonidine—Abdominal pain—Methotrexate—esophageal cancer	0.000272	0.00176	CcSEcCtD
Clonidine—Body temperature increased—Methotrexate—esophageal cancer	0.000272	0.00176	CcSEcCtD
Clonidine—Hypersensitivity—Methotrexate—esophageal cancer	0.000254	0.00164	CcSEcCtD
Clonidine—Asthenia—Methotrexate—esophageal cancer	0.000247	0.00159	CcSEcCtD
Clonidine—Pruritus—Methotrexate—esophageal cancer	0.000244	0.00157	CcSEcCtD
Clonidine—Diarrhoea—Methotrexate—esophageal cancer	0.000236	0.00152	CcSEcCtD
Clonidine—Dizziness—Methotrexate—esophageal cancer	0.000228	0.00147	CcSEcCtD
Clonidine—Vomiting—Methotrexate—esophageal cancer	0.000219	0.00141	CcSEcCtD
Clonidine—Rash—Methotrexate—esophageal cancer	0.000217	0.0014	CcSEcCtD
Clonidine—Dermatitis—Methotrexate—esophageal cancer	0.000217	0.0014	CcSEcCtD
Clonidine—Headache—Methotrexate—esophageal cancer	0.000216	0.00139	CcSEcCtD
Clonidine—Nausea—Methotrexate—esophageal cancer	0.000205	0.00132	CcSEcCtD
Clonidine—CYP1A2—Metabolism—CYP26A1—esophageal cancer	2.95e-05	0.000111	CbGpPWpGaD
Clonidine—ADRA2B—Signaling Pathways—TGFBR2—esophageal cancer	2.94e-05	0.000111	CbGpPWpGaD
Clonidine—ADRA2A—Metabolism—CYP19A1—esophageal cancer	2.88e-05	0.000108	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—SST—esophageal cancer	2.88e-05	0.000108	CbGpPWpGaD
Clonidine—CYP1A2—Metabolism—ALOX15—esophageal cancer	2.87e-05	0.000108	CbGpPWpGaD
Clonidine—ADRA2A—Hemostasis—EP300—esophageal cancer	2.84e-05	0.000107	CbGpPWpGaD
Clonidine—CYP2D6—Metabolism—GNG7—esophageal cancer	2.81e-05	0.000106	CbGpPWpGaD
Clonidine—CYP3A5—Metabolism—CYP1B1—esophageal cancer	2.81e-05	0.000106	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—GHRL—esophageal cancer	2.8e-05	0.000105	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—NOTCH3—esophageal cancer	2.8e-05	0.000105	CbGpPWpGaD
Clonidine—ABCB1—Metabolism—ALDH2—esophageal cancer	2.8e-05	0.000105	CbGpPWpGaD
Clonidine—CYP3A4—Metabolism—PLCE1—esophageal cancer	2.79e-05	0.000105	CbGpPWpGaD
Clonidine—CYP3A4—Metabolism—ADH7—esophageal cancer	2.79e-05	0.000105	CbGpPWpGaD
Clonidine—SLC22A3—Metabolism—PTGS2—esophageal cancer	2.79e-05	0.000105	CbGpPWpGaD
Clonidine—ADRA2B—Signaling Pathways—SMAD4—esophageal cancer	2.78e-05	0.000105	CbGpPWpGaD
Clonidine—ADRA2B—Hemostasis—PIK3CA—esophageal cancer	2.76e-05	0.000104	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—FBXW7—esophageal cancer	2.76e-05	0.000104	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—TGFBR2—esophageal cancer	2.75e-05	0.000103	CbGpPWpGaD
Clonidine—CYP1A2—Metabolism—GSTO1—esophageal cancer	2.74e-05	0.000103	CbGpPWpGaD
Clonidine—CYP1A2—Metabolism—TPI1—esophageal cancer	2.74e-05	0.000103	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—NOTCH2—esophageal cancer	2.71e-05	0.000102	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—TGFBR2—esophageal cancer	2.7e-05	0.000102	CbGpPWpGaD
Clonidine—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	2.69e-05	0.000101	CbGpPWpGaD
Clonidine—ADRA2B—Hemostasis—TP53—esophageal cancer	2.67e-05	0.000101	CbGpPWpGaD
Clonidine—ABCB1—Metabolism—GSTT1—esophageal cancer	2.66e-05	0.0001	CbGpPWpGaD
Clonidine—CYP1A1—Metabolism—CYP1B1—esophageal cancer	2.66e-05	9.98e-05	CbGpPWpGaD
Clonidine—CYP3A5—Metabolism—CYP19A1—esophageal cancer	2.64e-05	9.93e-05	CbGpPWpGaD
Clonidine—CYP2D6—Metabolism—ALDH2—esophageal cancer	2.64e-05	9.91e-05	CbGpPWpGaD
Clonidine—ADRA2A—Metabolism—HMOX1—esophageal cancer	2.63e-05	9.89e-05	CbGpPWpGaD
Clonidine—ABCB1—Metabolism—CYP2A6—esophageal cancer	2.63e-05	9.89e-05	CbGpPWpGaD
Clonidine—CYP1A2—Metabolism—ALDOB—esophageal cancer	2.63e-05	9.88e-05	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—SMAD4—esophageal cancer	2.6e-05	9.77e-05	CbGpPWpGaD
Clonidine—ADRA2C—Hemostasis—PIK3CA—esophageal cancer	2.58e-05	9.71e-05	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—SMAD4—esophageal cancer	2.56e-05	9.62e-05	CbGpPWpGaD
Clonidine—CYP1A2—Metabolism—GAPDH—esophageal cancer	2.53e-05	9.51e-05	CbGpPWpGaD
Clonidine—ADRA2A—Metabolism—ABCB1—esophageal cancer	2.53e-05	9.49e-05	CbGpPWpGaD
Clonidine—ADRA1D—Signaling Pathways—HIF1A—esophageal cancer	2.52e-05	9.48e-05	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—NOTCH2—esophageal cancer	2.51e-05	9.45e-05	CbGpPWpGaD
Clonidine—CYP2D6—Metabolism—GSTT1—esophageal cancer	2.51e-05	9.43e-05	CbGpPWpGaD
Clonidine—CYP1A2—Metabolism—CRABP1—esophageal cancer	2.51e-05	9.42e-05	CbGpPWpGaD
Clonidine—ADRA2C—Hemostasis—TP53—esophageal cancer	2.5e-05	9.39e-05	CbGpPWpGaD
Clonidine—CYP1A1—Metabolism—CYP19A1—esophageal cancer	2.5e-05	9.38e-05	CbGpPWpGaD
Clonidine—ABCB1—Metabolism—ENO1—esophageal cancer	2.49e-05	9.38e-05	CbGpPWpGaD
Clonidine—ABCB1—Metabolism—PTGS1—esophageal cancer	2.49e-05	9.38e-05	CbGpPWpGaD
Clonidine—ABCB1—Transmembrane transport of small molecules—CREBBP—esophageal cancer	2.49e-05	9.37e-05	CbGpPWpGaD
Clonidine—CYP2D6—Metabolism—CYP2A6—esophageal cancer	2.48e-05	9.32e-05	CbGpPWpGaD
Clonidine—ABCB1—Metabolism—PSME2—esophageal cancer	2.46e-05	9.24e-05	CbGpPWpGaD
Clonidine—ABCB1—Metabolism—PSME1—esophageal cancer	2.46e-05	9.24e-05	CbGpPWpGaD
Clonidine—CYP3A4—Metabolism—ADH1B—esophageal cancer	2.45e-05	9.2e-05	CbGpPWpGaD
Clonidine—ADRA1D—Signaling Pathways—KDR—esophageal cancer	2.41e-05	9.07e-05	CbGpPWpGaD
Clonidine—CYP3A5—Metabolism—HMOX1—esophageal cancer	2.41e-05	9.06e-05	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—TGFBR2—esophageal cancer	2.4e-05	9.03e-05	CbGpPWpGaD
Clonidine—CYP1A2—Metabolism—GNG7—esophageal cancer	2.38e-05	8.96e-05	CbGpPWpGaD
Clonidine—CYP2D6—Metabolism—PTGS1—esophageal cancer	2.35e-05	8.84e-05	CbGpPWpGaD
Clonidine—CYP2D6—Metabolism—ENO1—esophageal cancer	2.35e-05	8.84e-05	CbGpPWpGaD
Clonidine—CYP3A4—Metabolism—TYMP—esophageal cancer	2.34e-05	8.79e-05	CbGpPWpGaD
Clonidine—SLC22A3—Metabolism—EP300—esophageal cancer	2.32e-05	8.72e-05	CbGpPWpGaD
Clonidine—CYP2D6—Metabolism—PSME2—esophageal cancer	2.32e-05	8.71e-05	CbGpPWpGaD
Clonidine—CYP2D6—Metabolism—PSME1—esophageal cancer	2.32e-05	8.71e-05	CbGpPWpGaD
Clonidine—CYP3A5—Metabolism—ABCB1—esophageal cancer	2.31e-05	8.7e-05	CbGpPWpGaD
Clonidine—CYP1A1—Metabolism—HMOX1—esophageal cancer	2.28e-05	8.56e-05	CbGpPWpGaD
Clonidine—ADRA2B—Signaling Pathways—HIF1A—esophageal cancer	2.28e-05	8.56e-05	CbGpPWpGaD
Clonidine—CYP3A4—Metabolism—CYP26A1—esophageal cancer	2.27e-05	8.55e-05	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—SMAD4—esophageal cancer	2.27e-05	8.54e-05	CbGpPWpGaD
Clonidine—ADRA1D—Signaling Pathways—NOTCH1—esophageal cancer	2.27e-05	8.54e-05	CbGpPWpGaD
Clonidine—CYP1A1—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	2.23e-05	8.4e-05	CbGpPWpGaD
Clonidine—CYP1A2—Metabolism—ALDH2—esophageal cancer	2.23e-05	8.4e-05	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—TGFBR2—esophageal cancer	2.23e-05	8.39e-05	CbGpPWpGaD
Clonidine—CYP3A4—Metabolism—ALOX15—esophageal cancer	2.22e-05	8.33e-05	CbGpPWpGaD
Clonidine—CYP1A1—Metabolism—ABCB1—esophageal cancer	2.19e-05	8.22e-05	CbGpPWpGaD
Clonidine—ADRA2B—Signaling Pathways—KDR—esophageal cancer	2.18e-05	8.19e-05	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—HIF1A—esophageal cancer	2.13e-05	8e-05	CbGpPWpGaD
Clonidine—CYP1A2—Metabolism—GSTT1—esophageal cancer	2.12e-05	7.99e-05	CbGpPWpGaD
Clonidine—ABCB1—Metabolism—CYP1B1—esophageal cancer	2.12e-05	7.97e-05	CbGpPWpGaD
Clonidine—CYP3A4—Metabolism—TPI1—esophageal cancer	2.11e-05	7.95e-05	CbGpPWpGaD
Clonidine—CYP3A4—Metabolism—GSTO1—esophageal cancer	2.11e-05	7.95e-05	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—SMAD4—esophageal cancer	2.11e-05	7.94e-05	CbGpPWpGaD
Clonidine—CYP1A2—Metabolism—CYP2A6—esophageal cancer	2.1e-05	7.9e-05	CbGpPWpGaD
Clonidine—ADRA2A—Hemostasis—PIK3CA—esophageal cancer	2.1e-05	7.88e-05	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—HIF1A—esophageal cancer	2.09e-05	7.87e-05	CbGpPWpGaD
Clonidine—CYP1A2—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	2.09e-05	7.87e-05	CbGpPWpGaD
Clonidine—ADRA2C—Metabolism—CREBBP—esophageal cancer	2.08e-05	7.81e-05	CbGpPWpGaD
Clonidine—ADRA1D—Signaling Pathways—CREBBP—esophageal cancer	2.06e-05	7.75e-05	CbGpPWpGaD
Clonidine—ADRA2B—Signaling Pathways—NOTCH1—esophageal cancer	2.05e-05	7.71e-05	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—KDR—esophageal cancer	2.03e-05	7.65e-05	CbGpPWpGaD
Clonidine—ADRA2A—Hemostasis—TP53—esophageal cancer	2.03e-05	7.63e-05	CbGpPWpGaD
Clonidine—CYP3A4—Metabolism—ALDOB—esophageal cancer	2.03e-05	7.62e-05	CbGpPWpGaD
Clonidine—ADRA1D—Signaling by GPCR—EGFR—esophageal cancer	2.02e-05	7.61e-05	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—KDR—esophageal cancer	2e-05	7.53e-05	CbGpPWpGaD
Clonidine—CYP2D6—Metabolism—CYP1B1—esophageal cancer	2e-05	7.51e-05	CbGpPWpGaD
Clonidine—ABCB1—Metabolism—CYP19A1—esophageal cancer	1.99e-05	7.5e-05	CbGpPWpGaD
Clonidine—SLC22A1—Metabolism—CREBBP—esophageal cancer	1.99e-05	7.49e-05	CbGpPWpGaD
Clonidine—CYP1A2—Metabolism—ENO1—esophageal cancer	1.99e-05	7.49e-05	CbGpPWpGaD
Clonidine—CYP1A2—Metabolism—PTGS1—esophageal cancer	1.99e-05	7.49e-05	CbGpPWpGaD
Clonidine—CYP1A2—Metabolism—PSME1—esophageal cancer	1.96e-05	7.38e-05	CbGpPWpGaD
Clonidine—CYP1A2—Metabolism—PSME2—esophageal cancer	1.96e-05	7.38e-05	CbGpPWpGaD
Clonidine—CYP3A4—Metabolism—GAPDH—esophageal cancer	1.95e-05	7.34e-05	CbGpPWpGaD
Clonidine—ADRA1D—GPCR downstream signaling—PIK3CA—esophageal cancer	1.94e-05	7.27e-05	CbGpPWpGaD
Clonidine—CYP3A4—Metabolism—CRABP1—esophageal cancer	1.93e-05	7.27e-05	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—NOTCH1—esophageal cancer	1.92e-05	7.2e-05	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—NOTCH1—esophageal cancer	1.89e-05	7.09e-05	CbGpPWpGaD
Clonidine—CYP2D6—Metabolism—CYP19A1—esophageal cancer	1.88e-05	7.06e-05	CbGpPWpGaD
Clonidine—ADRA2C—Metabolism—NOS3—esophageal cancer	1.86e-05	6.99e-05	CbGpPWpGaD
Clonidine—ADRA2B—Signaling Pathways—CREBBP—esophageal cancer	1.86e-05	6.99e-05	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—HIF1A—esophageal cancer	1.86e-05	6.99e-05	CbGpPWpGaD
Clonidine—ADRA1D—Signaling Pathways—NOS3—esophageal cancer	1.84e-05	6.94e-05	CbGpPWpGaD
Clonidine—CYP3A4—Metabolism—GNG7—esophageal cancer	1.84e-05	6.92e-05	CbGpPWpGaD
Clonidine—ADRA2B—Signaling by GPCR—EGFR—esophageal cancer	1.83e-05	6.87e-05	CbGpPWpGaD
Clonidine—ABCB1—Metabolism—HMOX1—esophageal cancer	1.82e-05	6.84e-05	CbGpPWpGaD
Clonidine—SLC22A1—Metabolism—NOS3—esophageal cancer	1.78e-05	6.7e-05	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—KDR—esophageal cancer	1.78e-05	6.69e-05	CbGpPWpGaD
Clonidine—ADRA1D—Signaling by GPCR—PIK3CA—esophageal cancer	1.76e-05	6.61e-05	CbGpPWpGaD
Clonidine—ADRA2B—GPCR downstream signaling—PIK3CA—esophageal cancer	1.75e-05	6.57e-05	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—CREBBP—esophageal cancer	1.74e-05	6.53e-05	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—HIF1A—esophageal cancer	1.73e-05	6.5e-05	CbGpPWpGaD
Clonidine—ADRA1D—Signaling Pathways—ERBB2—esophageal cancer	1.73e-05	6.49e-05	CbGpPWpGaD
Clonidine—CYP3A4—Metabolism—ALDH2—esophageal cancer	1.72e-05	6.48e-05	CbGpPWpGaD
Clonidine—SLC22A3—Metabolism—PIK3CA—esophageal cancer	1.72e-05	6.45e-05	CbGpPWpGaD
Clonidine—CYP2D6—Metabolism—HMOX1—esophageal cancer	1.71e-05	6.45e-05	CbGpPWpGaD
Clonidine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	1.71e-05	6.44e-05	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—CREBBP—esophageal cancer	1.71e-05	6.43e-05	CbGpPWpGaD
Clonidine—ADRA2C—Signaling by GPCR—EGFR—esophageal cancer	1.71e-05	6.42e-05	CbGpPWpGaD
Clonidine—ADRA2C—Metabolism—PTGS2—esophageal cancer	1.7e-05	6.4e-05	CbGpPWpGaD
Clonidine—CYP1A2—Metabolism—CYP1B1—esophageal cancer	1.69e-05	6.36e-05	CbGpPWpGaD
Clonidine—ADRA2A—Metabolism—CREBBP—esophageal cancer	1.69e-05	6.35e-05	CbGpPWpGaD
Clonidine—ADRA1B—Signaling by GPCR—EGFR—esophageal cancer	1.68e-05	6.32e-05	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—NOTCH1—esophageal cancer	1.68e-05	6.3e-05	CbGpPWpGaD
Clonidine—ADRA2B—Signaling Pathways—NOS3—esophageal cancer	1.67e-05	6.26e-05	CbGpPWpGaD
Clonidine—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	1.65e-05	6.21e-05	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—KDR—esophageal cancer	1.65e-05	6.21e-05	CbGpPWpGaD
Clonidine—CYP2D6—Metabolism—ABCB1—esophageal cancer	1.65e-05	6.19e-05	CbGpPWpGaD
Clonidine—CYP3A4—Metabolism—GSTT1—esophageal cancer	1.64e-05	6.16e-05	CbGpPWpGaD
Clonidine—ADRA2C—GPCR downstream signaling—PIK3CA—esophageal cancer	1.63e-05	6.13e-05	CbGpPWpGaD
Clonidine—SLC22A1—Metabolism—PTGS2—esophageal cancer	1.63e-05	6.13e-05	CbGpPWpGaD
Clonidine—CYP3A4—Metabolism—CYP2A6—esophageal cancer	1.62e-05	6.09e-05	CbGpPWpGaD
Clonidine—ADRA1B—GPCR downstream signaling—PIK3CA—esophageal cancer	1.61e-05	6.04e-05	CbGpPWpGaD
Clonidine—CYP1A2—Metabolism—CYP19A1—esophageal cancer	1.59e-05	5.98e-05	CbGpPWpGaD
Clonidine—ADRA2B—Signaling by GPCR—PIK3CA—esophageal cancer	1.59e-05	5.96e-05	CbGpPWpGaD
Clonidine—ADRA2B—Signaling Pathways—ERBB2—esophageal cancer	1.56e-05	5.86e-05	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—NOTCH1—esophageal cancer	1.56e-05	5.85e-05	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—NOS3—esophageal cancer	1.56e-05	5.85e-05	CbGpPWpGaD
Clonidine—CYP3A5—Metabolism—CREBBP—esophageal cancer	1.55e-05	5.81e-05	CbGpPWpGaD
Clonidine—CYP3A4—Metabolism—PTGS1—esophageal cancer	1.54e-05	5.78e-05	CbGpPWpGaD
Clonidine—CYP3A4—Metabolism—ENO1—esophageal cancer	1.54e-05	5.78e-05	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—NOS3—esophageal cancer	1.53e-05	5.76e-05	CbGpPWpGaD
Clonidine—ADRA1D—Signaling Pathways—CCND1—esophageal cancer	1.52e-05	5.73e-05	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—CREBBP—esophageal cancer	1.52e-05	5.71e-05	CbGpPWpGaD
Clonidine—CYP3A4—Metabolism—PSME2—esophageal cancer	1.51e-05	5.69e-05	CbGpPWpGaD
Clonidine—CYP3A4—Metabolism—PSME1—esophageal cancer	1.51e-05	5.69e-05	CbGpPWpGaD
Clonidine—ADRA2A—Metabolism—NOS3—esophageal cancer	1.51e-05	5.68e-05	CbGpPWpGaD
Clonidine—ADRA1A—Signaling by GPCR—EGFR—esophageal cancer	1.49e-05	5.61e-05	CbGpPWpGaD
Clonidine—ADRA2C—Signaling by GPCR—PIK3CA—esophageal cancer	1.48e-05	5.57e-05	CbGpPWpGaD
Clonidine—ADRA1D—Signaling Pathways—CDKN1A—esophageal cancer	1.47e-05	5.54e-05	CbGpPWpGaD
Clonidine—CYP1A1—Metabolism—CREBBP—esophageal cancer	1.46e-05	5.49e-05	CbGpPWpGaD
Clonidine—ADRA1B—Signaling by GPCR—PIK3CA—esophageal cancer	1.46e-05	5.48e-05	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—ERBB2—esophageal cancer	1.46e-05	5.47e-05	CbGpPWpGaD
Clonidine—CYP1A2—Metabolism—HMOX1—esophageal cancer	1.45e-05	5.46e-05	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—ERBB2—esophageal cancer	1.43e-05	5.38e-05	CbGpPWpGaD
Clonidine—ADRA1A—GPCR downstream signaling—PIK3CA—esophageal cancer	1.43e-05	5.36e-05	CbGpPWpGaD
Clonidine—CYP1A2—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	1.42e-05	5.36e-05	CbGpPWpGaD
Clonidine—ADRA2C—Metabolism—EP300—esophageal cancer	1.42e-05	5.32e-05	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—CREBBP—esophageal cancer	1.41e-05	5.31e-05	CbGpPWpGaD
Clonidine—ADRA1D—Signaling Pathways—EP300—esophageal cancer	1.4e-05	5.28e-05	CbGpPWpGaD
Clonidine—CYP1A2—Metabolism—ABCB1—esophageal cancer	1.39e-05	5.24e-05	CbGpPWpGaD
Clonidine—ADRA2A—Signaling by GPCR—EGFR—esophageal cancer	1.39e-05	5.21e-05	CbGpPWpGaD
Clonidine—CYP3A5—Metabolism—NOS3—esophageal cancer	1.38e-05	5.21e-05	CbGpPWpGaD
Clonidine—ADRA2A—Metabolism—PTGS2—esophageal cancer	1.38e-05	5.2e-05	CbGpPWpGaD
Clonidine—ADRA2B—Signaling Pathways—CCND1—esophageal cancer	1.38e-05	5.17e-05	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—NOS3—esophageal cancer	1.36e-05	5.11e-05	CbGpPWpGaD
Clonidine—SLC22A1—Metabolism—EP300—esophageal cancer	1.36e-05	5.1e-05	CbGpPWpGaD
Clonidine—ADRA2B—Signaling Pathways—CDKN1A—esophageal cancer	1.33e-05	5.01e-05	CbGpPWpGaD
Clonidine—ADRA2A—GPCR downstream signaling—PIK3CA—esophageal cancer	1.33e-05	4.98e-05	CbGpPWpGaD
Clonidine—CYP1A1—Metabolism—NOS3—esophageal cancer	1.31e-05	4.92e-05	CbGpPWpGaD
Clonidine—CYP3A4—Metabolism—CYP1B1—esophageal cancer	1.31e-05	4.91e-05	CbGpPWpGaD
Clonidine—ADRA1A—Signaling by GPCR—PIK3CA—esophageal cancer	1.3e-05	4.87e-05	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—CCND1—esophageal cancer	1.29e-05	4.83e-05	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—ERBB2—esophageal cancer	1.27e-05	4.78e-05	CbGpPWpGaD
Clonidine—ADRA2B—Signaling Pathways—EP300—esophageal cancer	1.27e-05	4.76e-05	CbGpPWpGaD
Clonidine—CYP3A5—Metabolism—PTGS2—esophageal cancer	1.27e-05	4.76e-05	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—CCND1—esophageal cancer	1.27e-05	4.76e-05	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—NOS3—esophageal cancer	1.26e-05	4.75e-05	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—CDKN1A—esophageal cancer	1.24e-05	4.68e-05	CbGpPWpGaD
Clonidine—CYP3A4—Metabolism—CYP19A1—esophageal cancer	1.23e-05	4.62e-05	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—CDKN1A—esophageal cancer	1.22e-05	4.6e-05	CbGpPWpGaD
Clonidine—ADRA1D—Signaling Pathways—MYC—esophageal cancer	1.22e-05	4.6e-05	CbGpPWpGaD
Clonidine—ADRA2A—Signaling by GPCR—PIK3CA—esophageal cancer	1.2e-05	4.53e-05	CbGpPWpGaD
Clonidine—CYP1A1—Metabolism—PTGS2—esophageal cancer	1.2e-05	4.5e-05	CbGpPWpGaD
Clonidine—ADRA1D—Signaling Pathways—EGFR—esophageal cancer	1.2e-05	4.5e-05	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—EP300—esophageal cancer	1.18e-05	4.45e-05	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—ERBB2—esophageal cancer	1.18e-05	4.44e-05	CbGpPWpGaD
Clonidine—ABCB1—Metabolism—CREBBP—esophageal cancer	1.17e-05	4.39e-05	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—EP300—esophageal cancer	1.16e-05	4.38e-05	CbGpPWpGaD
Clonidine—ADRA2A—Metabolism—EP300—esophageal cancer	1.15e-05	4.32e-05	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—CCND1—esophageal cancer	1.12e-05	4.23e-05	CbGpPWpGaD
Clonidine—CYP3A4—Metabolism—HMOX1—esophageal cancer	1.12e-05	4.21e-05	CbGpPWpGaD
Clonidine—ADRA2B—Signaling Pathways—MYC—esophageal cancer	1.1e-05	4.15e-05	CbGpPWpGaD
Clonidine—CYP2D6—Metabolism—CREBBP—esophageal cancer	1.1e-05	4.13e-05	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—CDKN1A—esophageal cancer	1.09e-05	4.09e-05	CbGpPWpGaD
Clonidine—ADRA2B—Signaling Pathways—EGFR—esophageal cancer	1.08e-05	4.06e-05	CbGpPWpGaD
Clonidine—CYP3A4—Metabolism—ABCB1—esophageal cancer	1.08e-05	4.04e-05	CbGpPWpGaD
Clonidine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	1.05e-05	3.96e-05	CbGpPWpGaD
Clonidine—CYP3A5—Metabolism—EP300—esophageal cancer	1.05e-05	3.96e-05	CbGpPWpGaD
Clonidine—ADRA2C—Metabolism—PIK3CA—esophageal cancer	1.05e-05	3.94e-05	CbGpPWpGaD
Clonidine—ABCB1—Metabolism—NOS3—esophageal cancer	1.04e-05	3.93e-05	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—CCND1—esophageal cancer	1.04e-05	3.93e-05	CbGpPWpGaD
Clonidine—ADRA1D—Signaling Pathways—PIK3CA—esophageal cancer	1.04e-05	3.9e-05	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—EP300—esophageal cancer	1.03e-05	3.89e-05	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—MYC—esophageal cancer	1.03e-05	3.88e-05	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—MYC—esophageal cancer	1.01e-05	3.82e-05	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—CDKN1A—esophageal cancer	1.01e-05	3.8e-05	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—EGFR—esophageal cancer	1.01e-05	3.79e-05	CbGpPWpGaD
Clonidine—ADRA1D—Signaling Pathways—TP53—esophageal cancer	1e-05	3.78e-05	CbGpPWpGaD
Clonidine—SLC22A1—Metabolism—PIK3CA—esophageal cancer	1e-05	3.77e-05	CbGpPWpGaD
Clonidine—CYP1A1—Metabolism—EP300—esophageal cancer	9.95e-06	3.74e-05	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—EGFR—esophageal cancer	9.93e-06	3.73e-05	CbGpPWpGaD
Clonidine—CYP2D6—Metabolism—NOS3—esophageal cancer	9.85e-06	3.7e-05	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—EP300—esophageal cancer	9.61e-06	3.61e-05	CbGpPWpGaD
Clonidine—ABCB1—Metabolism—PTGS2—esophageal cancer	9.56e-06	3.59e-05	CbGpPWpGaD
Clonidine—ADRA2B—Signaling Pathways—PIK3CA—esophageal cancer	9.37e-06	3.52e-05	CbGpPWpGaD
Clonidine—CYP1A2—Metabolism—CREBBP—esophageal cancer	9.32e-06	3.5e-05	CbGpPWpGaD
Clonidine—ADRA2B—Signaling Pathways—TP53—esophageal cancer	9.07e-06	3.41e-05	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—MYC—esophageal cancer	9.01e-06	3.39e-05	CbGpPWpGaD
Clonidine—CYP2D6—Metabolism—PTGS2—esophageal cancer	9.01e-06	3.39e-05	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—EGFR—esophageal cancer	8.82e-06	3.31e-05	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—PIK3CA—esophageal cancer	8.75e-06	3.29e-05	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—PIK3CA—esophageal cancer	8.62e-06	3.24e-05	CbGpPWpGaD
Clonidine—ADRA2A—Metabolism—PIK3CA—esophageal cancer	8.5e-06	3.2e-05	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—TP53—esophageal cancer	8.47e-06	3.18e-05	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—MYC—esophageal cancer	8.38e-06	3.15e-05	CbGpPWpGaD
Clonidine—CYP1A2—Metabolism—NOS3—esophageal cancer	8.34e-06	3.14e-05	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—TP53—esophageal cancer	8.33e-06	3.13e-05	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—EGFR—esophageal cancer	8.19e-06	3.08e-05	CbGpPWpGaD
Clonidine—ABCB1—Metabolism—EP300—esophageal cancer	7.95e-06	2.99e-05	CbGpPWpGaD
Clonidine—CYP3A5—Metabolism—PIK3CA—esophageal cancer	7.79e-06	2.93e-05	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—PIK3CA—esophageal cancer	7.65e-06	2.88e-05	CbGpPWpGaD
Clonidine—CYP1A2—Metabolism—PTGS2—esophageal cancer	7.63e-06	2.87e-05	CbGpPWpGaD
Clonidine—CYP2D6—Metabolism—EP300—esophageal cancer	7.49e-06	2.82e-05	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—TP53—esophageal cancer	7.4e-06	2.78e-05	CbGpPWpGaD
Clonidine—CYP1A1—Metabolism—PIK3CA—esophageal cancer	7.36e-06	2.77e-05	CbGpPWpGaD
Clonidine—CYP3A4—Metabolism—CREBBP—esophageal cancer	7.19e-06	2.7e-05	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—PIK3CA—esophageal cancer	7.11e-06	2.67e-05	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—TP53—esophageal cancer	6.88e-06	2.59e-05	CbGpPWpGaD
Clonidine—CYP3A4—Metabolism—NOS3—esophageal cancer	6.44e-06	2.42e-05	CbGpPWpGaD
Clonidine—CYP1A2—Metabolism—EP300—esophageal cancer	6.35e-06	2.39e-05	CbGpPWpGaD
Clonidine—CYP3A4—Metabolism—PTGS2—esophageal cancer	5.89e-06	2.21e-05	CbGpPWpGaD
Clonidine—ABCB1—Metabolism—PIK3CA—esophageal cancer	5.88e-06	2.21e-05	CbGpPWpGaD
Clonidine—CYP2D6—Metabolism—PIK3CA—esophageal cancer	5.54e-06	2.08e-05	CbGpPWpGaD
Clonidine—CYP3A4—Metabolism—EP300—esophageal cancer	4.9e-06	1.84e-05	CbGpPWpGaD
Clonidine—CYP1A2—Metabolism—PIK3CA—esophageal cancer	4.69e-06	1.76e-05	CbGpPWpGaD
Clonidine—CYP3A4—Metabolism—PIK3CA—esophageal cancer	3.62e-06	1.36e-05	CbGpPWpGaD
